SITC Cancer Immunotherapy Guidelines - Non-Small Cell Lung Cancer (NSCLC) Webinar

When:  Sep 13, 2018 from 1:00 PM to 2:00 PM (ET)

Join leading experts in cancer immunotherapy for the SITC Cancer Immunotherapy Guidelines - Non-Small Cell Lung Cancer (NSCLC) Webinar.

sitc_log_color.pngThis FREE CME-, CNE-, CPE-certified webinar is a chance for clinicians to learn about the recommendations from the recently published guideline, The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).

Register Now Download Promotional Flyer

The webinar faculty will present and discuss:

  • The role of immunotherapy for the treatment of NSCLC
  • The role of patient biomarker testing for prognostic use as well as optimizing treatment selection
  • Unique disease cases that may require adaption of immunotherapy utilization
  • How best to manage immune-related adverse events

A dedicated question-and-answer session during the webinar will provide an opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.


Webinar Faculty:

  • Roy S. Herbst, MD, PhD – Yale Cancer Center
  • Julie R. Brahmer, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Patrick Forde, MD – Johns Hopkins University
  • Scott N. Gettinger, MD – Yale Cancer Center 
Click HERE to register for the webinar!


Webinar Agenda:
1:00–1:05 p.m. EDT  Welcome and introductions
1:05–1:40 p.m. EDT  Presentation and discussion of Guideline content 
1:40–1:55 p.m. EDT  Question and answer session
1:55–2:00 p.m. EDT  Closing remarks


Continuing Education Credits are available for physicians, nurses and pharmacists. 

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer

#CME #CPE #CNE #Biomarkers #LungCancers #Webinar #Oncologist #Clinician #Nurse #Pharmacist #AdverseEvents #CancerImmunotherapyGuidelines